Small-Molecule Probes Reveal Esterases with Persistent Activity in Dormant and Reactivating Mycobacterium tuberculosis.
Mycobacterium tuberculosis (Mtb) is the deadliest bacterial pathogen in the world. An estimated one-third of humans harbor Mtb in a dormant state. These asymptomatic, latent infections impede tuberculosis eradication due to the long-term potential for reactivation. Dormant Mtb has reduced enzymatic activity, but hydrolases that remain active facilitate pathogen survival. We targeted Mtb esterases, a diverse set of enzymes in the serine hydrolase family, and studied their activities using both activity-based probes (ABPs) and fluorogenic esterase substrates. These small-molecule probes revealed functional esterases in active, dormant, and reactivating cultures. Using ABPs, we identified five esterases that remained active in dormant Mtb, including LipM (Rv2284), LipN (Rv2970c), CaeA (Rv2224c), Rv0183, and Rv1683. Three of these, CaeA, Rv0183, and Rv1683, were catalytically active in all three culture conditions. Fluorogenic probes additionally revealed LipH (Rv1399c), Culp1 (Rv1984c), and Rv3036c esterase activity in dormant and active cultures. Esterases with persistent activity are potential diagnostic biomarkers or therapeutic targets for Mtb-infected individuals with latent or active tuberculosis.
Program in Chemical Biology and Department of Biomedical Engineering, Oregon Health & Science University , Mail Code CL3B, 2730 S.W. Moody Avenue, Portland, Oregon 97201, United States.
Katie R
KR
Tallman
Program in Chemical Biology and Department of Biomedical Engineering, Oregon Health & Science University , Mail Code CL3B, 2730 S.W. Moody Avenue, Portland, Oregon 97201, United States.
Samantha R
SR
Levine
Program in Chemical Biology and Department of Biomedical Engineering, Oregon Health & Science University , Mail Code CL3B, 2730 S.W. Moody Avenue, Portland, Oregon 97201, United States.
Kimberly E
KE
Beatty
D000995:Antitubercular Agents / Q000737:chemistry / Q000494:pharmacology*; D001426:Bacterial Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism; D004353:Drug Evaluation, Preclinical; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000494:pharmacology*; D004950:Esterases / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism; D006801:Humans; D055985:Latent Tuberculosis / Q000382:microbiology*; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000201:enzymology* / Q000235:genetics; D014376:Tuberculosis / Q000382:microbiology
D000995:Antitubercular Agents; D001426:Bacterial Proteins; D004791:Enzyme Inhibitors; D004950:Esterases
Mycobacterium tuberculosis; chemical biology; esterase; fluorescent; proteomics
Immunol Rev. 2015 Mar;264(1):308-18
25703568
Nat Commun. 2013;4:2748
24193546
Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7521-6
20368441
Trends Cell Biol. 2004 Jan;14(1):29-35
14729178
Protein Expr Purif. 2014 Dec;104:50-6
25224799
J Bacteriol. 2010 Sep;192(18):4776-85
20601476
Appl Microbiol Biotechnol. 2008 Apr;78(5):741-9
18309478
Nat Rev Microbiol. 2009 Dec;7(12):845-55
19855401
J Biol Chem. 2011 May 27;286(21):19024-34
21471225
Mol Microbiol. 2003 May;48(3):833-43
12694625
J Bacteriol. 2004 Aug;186(15):5017-30
15262939
Lancet Infect Dis. 2003 Sep;3(9):578-90
12954564
Annu Rev Biochem. 2008;77:383-414
18366325
J Bacteriol. 1933 Aug;26(2):139-66
16559649
Mol Microbiol. 2003 Apr;48(1):77-84
12657046
Clin Immunol. 2007 Nov;125(2):173-83
17766185
Infect Immun. 2005 Feb;73(2):1196-203
15664964
Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):12911-6
23878250
J Biol Chem. 2007 Jun 22;282(25):18348-18356
17428787
Cell Host Microbe. 2015 Jul 8;18(1):96-108
26094805
PLoS One. 2009 Jun 29;4(6):e6077
19562030
PLoS One. 2008 Jan 30;3(1):e1502
18231589
Drug Discov Today. 2012 May;17(9-10):514-21
22198298
Chem Biol. 2011 Nov 23;18(11):1432-41
22118677
Mol Microbiol. 2002 Feb;43(3):717-31
11929527
BMC Microbiol. 2010 Apr 29;10:132
20429878
PLoS One. 2009;4(1):e4281
19169353
Mol Cell Proteomics. 2014 Feb;13(2):435-48
24345785
Nature. 2013 Jul 11;499(7457):178-83
23823726
PLoS One. 2010 Nov 11;5(11):e13938
21085642
Int J Biochem Cell Biol. 2015 Feb;59:193-202
25456444
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15629-34
16227431
Nat Rev Drug Discov. 2012 Jan 03;11(1):52-68
22212679
FASEB J. 2010 Jun;24(6):1893-903
20103719
Biochem J. 2007 Dec 15;408(3):417-27
17784850
J Bacteriol. 2009 Aug;191(16):5037-43
19525349
Protein Expr Purif. 2006 Aug;48(2):274-80
16716602
ACS Chem Biol. 2016 Jul 15;11(7):1810-5
27177211
Cell Host Microbe. 2008 Mar 13;3(3):137-45
18329613
Mol Cell Proteomics. 2015 Aug;14(8):2160-76
26025969
PLoS One. 2011;6(9):e25078
21966416
PLoS One. 2012;7(9):e46493
23029536
Chembiochem. 2014 May 26;15(8):1101-5
24764280
J Biol Chem. 2014 Sep 5;289(36):25031-40
25028518
ACS Chem Biol. 2013 Oct 18;8(10):2224-34
23898841
Chem Biol Drug Des. 2012 Jun;79(6):1056-62
22405030
J Med Chem. 2012 Nov 26;55(22):10204-19
23095026
Mol Cell Biochem. 2014 Nov;396(1-2):187-99
25091806
Methods Mol Med. 2001;54:247-69
21341080
J Biol Chem. 2006 Feb 17;281(7):3866-75
16354661
Cell Chem Biol. 2016 Feb 18;23(2):290-298
26853625
J Med Chem. 2013 Jun 13;56(11):4393-401
23651298
Biochemistry. 2001 Apr 3;40(13):4005-15
11300781
Chembiochem. 2015 Jan 2;16(1):70-5
25469918
Proc Natl Acad Sci U S A. 2008 Jan 8;105(1):264-9
18172199